October 11,2017
the staff of the Ridgewood blog
NEWARK NJ, The Attorney General is proposing new rules concerning limitations on and obligations associated with the acceptance of compensation from pharmaceutical manufacturers. The public may submit written comments to this proposal through December 1, 2017.
The proposed rules establish principled standards to minimize the potential for conflicts of interest between prescribers and pharmaceutical manufacturers to ensure that patient care is guided by the unbiased, best judgment of the treating prescriber.
The proposed rules strengthen and clarify existing limitations for licensees of the Boards of Medical Examiners, Dentistry and Optometry, and extends those standards to Advanced Practice Nurses, the only Board of Nursing licensees with prescribing authority.
In connection with this notice of proposal, the Attorney General will hold a public hearing to take testimony from interested parties to gather facts to inform the proposed rulemaking and to afford ample opportunity for the receipt of public comment from the regulated communities, industry representatives, and the public at large.
The public hearing will be held on Thursday, October 19, 2017.
